Plain-English translation of NCT05387551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial examined whether using a continuous glucose monitor (CGM)—a small wearable device that tracks blood sugar levels throughout the day—could help young people with impaired glucose tolerance (early warning signs of diabetes) benefit more from lifestyle changes like diet and exercise. The researchers studied whether real-time blood sugar information would motivate better health choices and help prevent diabetes from developing.
Young people with early warning signs of diabetes face serious health risks if the condition progresses. This trial investigated whether seeing real-time glucose data could give patients and families extra motivation and information to make healthier choices and reverse these early warning signs before diabetes develops.
Participants received a Dexcom G6 continuous glucose monitor to wear on their arm, which tracked their blood sugar levels throughout daily activities and sent real-time data to a smartphone or receiver. They worked with the research team on lifestyle modifications like changes to diet and exercise while using the glucose monitor data to guide their health decisions. The trial studied whether this combination of real-time glucose information and lifestyle support helped improve how their bodies used insulin.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States